Tolfenamic Acid Dosing Recommendations
For acute migraine, the recommended dose of tolfenamic acid is 200 mg orally at the onset of attack, which may be repeated after 2 hours if needed. 1
Dosing by Indication
Acute Migraine
- Initial dose: 200 mg orally at attack onset
- Repeat dosing: May take an additional 200 mg after 2 hours if the attack has not abated 2, 3, 4
- Maximum: Studies have evaluated up to 400 mg per attack 3
- Tolfenamic acid is recognized as first-line NSAID therapy for acute migraine with consistent evidence supporting its efficacy 1
Dysmenorrhea, Rheumatoid Arthritis, and Osteoarthritis
The provided evidence does not contain specific FDA-approved dosing for tolfenamic acid for these indications. However, reference data from diclofenac potassium (a comparable NSAID) suggests 5:
- Dysmenorrhea: 50 mg three times daily
- Rheumatoid arthritis: 150-200 mg/day in divided doses (50 mg 3-4 times daily)
- Osteoarthritis: 100-150 mg/day in divided doses (50 mg 2-3 times daily)
For chronic inflammatory conditions like rheumatoid arthritis, research indicates tolfenamic acid has been used at 600 mg daily for prolonged treatment (up to 6 months) with acceptable tolerability 6.
Special Populations
Elderly Patients
No specific dose reduction is recommended based on age alone for tolfenamic acid. However, clinical judgment should guide dosing:
- Start with the standard 200 mg dose for migraine
- Monitor closely for adverse effects, particularly gastrointestinal and renal complications
- NSAIDs carry increased risk in elderly patients, with one study showing NSAIDs implicated in 23.5% of drug-related hospitalizations in older adults 7
Renal Impairment
The evidence does not provide specific tolfenamic acid dosing adjustments for renal impairment. General NSAID principles apply:
- Mild to moderate renal disease: Use with caution; standard dosing may be appropriate with close monitoring 8
- Severe renal disease (CrCl <30 mL/min): NSAIDs should generally be avoided due to risk of further renal deterioration 9, 8
- Consider alternative therapies such as gepants (ubrogepant, rimegepant) which are safer in renal disease 9, 8
Hepatic Impairment
No specific tolfenamic acid dosing guidelines exist for hepatic impairment in the provided evidence. General approach:
- Mild to moderate hepatic disease: May use standard dosing with monitoring 8
- Severe hepatic disease: Avoid NSAIDs due to risk of hepatotoxicity and gastrointestinal bleeding 8
- Alternative acute migraine therapies like gepants may be preferable with appropriate dose adjustments 9, 8
Important Clinical Considerations
Common pitfalls to avoid:
- Do not use tolfenamic acid more than 2 days per week to prevent medication-overuse headache 1
- NSAIDs are contraindicated in patients with aspirin/NSAID-induced asthma 10
- Exercise particular caution in patients with cardiovascular disease, as NSAIDs carry cardiovascular risks 9
- The combination of tolfenamic acid with caffeine (100 mg) has shown enhanced efficacy in migraine treatment 2, 4
Side effects: In long-term studies, diarrhea occurred in 8.8% of patients, other gastrointestinal disturbances in 12%, and dysuria in 8.8% of cases 6. Most side effects were mild and reversible.